Crossmark

Investigation of structure–activity relationship: In silico studies of [1, 2, 4]triazolo[4, 3-a]pyridine ureas as P38 kinase inhibitors

Published Online: 2022-09-13

Published Print: 2023-06

Authors

Aasiya, Choudhary

Mangala, Khandekar

Chandrakant, Bagul

Muthal, Amol

Kulkarni, Ravindra https://orcid.org/0000-0001-9455-7958
License Information

Text and Data Mining valid from 2022-09-13

Version of Record valid from 2022-09-13
More Information

Article History

Received: 20 May 2022

Accepted: 25 August 2022

First Online: 13 September 2022

Declarations

:

: The authors declare no competing interests.

Document is current